Chemed Corporation (CHE)
NYSE: CHE · Real-Time Price · USD
460.40
-3.38 (-0.73%)
Sep 9, 2025, 11:56 AM - Market open
Chemed Analyst Ratings
Total Analysts
4
Consensus Rating
Strong Buy
Price Target
$592.25
Upside
+28.64%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Hold → Strong Buy Upgrades $490 → $550 | Hold → Strong Buy | Upgrades | $490 → $550 | +19.46% | Sep 2, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $640 → $589 | Buy | Maintains | $640 → $589 | +27.93% | Jul 31, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $650 → $580 | Buy | Maintains | $650 → $580 | +25.98% | Jul 31, 2025 |
| Jefferies | Jefferies | Hold Initiates $500 | Hold | Initiates | $500 | +8.60% | Jul 25, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $674 → $640 | Buy | Maintains | $674 → $640 | +39.01% | Jun 30, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $708 → $650 | Strong Buy | Maintains | $708 → $650 | +41.18% | Jun 30, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $667 → $674 | Buy | Maintains | $667 → $674 | +46.39% | Apr 28, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $633 → $667 | Buy | Maintains | $633 → $667 | +44.87% | Mar 14, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $697 → $633 | Buy | Maintains | $697 → $633 | +37.49% | Nov 5, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $712 → $697 | Buy | Maintains | $712 → $697 | +51.39% | May 21, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $604 → $712 | Buy | Maintains | $604 → $712 | +54.65% | Mar 4, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $625 → $650 | Buy | Maintains | $625 → $650 | +41.18% | Feb 29, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $590 → $625 | Buy | Maintains | $590 → $625 | +35.75% | Jan 17, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $576 → $604 | Buy | Maintains | $576 → $604 | +31.19% | Oct 30, 2023 |
| RBC Capital | RBC Capital | Buy Maintains $610 → $576 | Buy | Maintains | $610 → $576 | +25.11% | Jul 31, 2023 |
| Oppenheimer | Oppenheimer | Buy Maintains $610 → $590 | Buy | Maintains | $610 → $590 | +28.15% | Jul 27, 2023 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.